To confirm the role of LPAR3 in LPA-meditated geminin upregulation, we evaluated geminin protein levels in gastric cancer cells treated with the LPAR1/3 inhibitor Ki16425 by Western blotting. The gene discussed is GMNN; the disease is gastric cancer.